Metraipolis › archive › dc_bb4fc99de781
MOG-Ab-associated optic neuritis with concurrent GFAP-Ab positivity following tislelizumab-based treatment: a case report — Europe PMC PMID:42466004
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42466004
- DOI
- 10.3389/fphar.2026.1834795
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T11:50:00.855Z
- SHA-256 of the archived text
823d93eec35d3f0c68f14e4bf941e9e92f3af4b74834b35fe87e4954714583ed- Stable URL of this page
https://metraipolis.com/documento/dc_bb4fc99de781
How to cite
MOG-Ab-associated optic neuritis with concurrent GFAP-Ab positivity following tislelizumab-based treatment: a case report — Europe PMC PMID:42466004 — Europe PMC (en), https://europepmc.org/article/MED/42466004 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb4fc99de781 (Metraipolis archive dc_bb4fc99de781, sha256 823d93eec35d3f0c68f14e4bf941e9e92f3af4b74834b35fe87e4954714583ed)
BibTeX
@misc{dcbb4fc99de781,
title = {MOG-Ab-associated optic neuritis with concurrent GFAP-Ab positivity following tislelizumab-based treatment: a case report — Europe PMC PMID:42466004},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42466004},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb4fc99de781; sha256 823d93eec35d3f0c68f14e4bf941e9e92f3af4b74834b35fe87e4954714583ed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42466004. Agents can read the archived copy with the MCP tool read_document.